The EGFR-inducing activity of Celecoxib was not confined to colon TAFs, as also normal fibroblasts from colon mucosa and some CRC cell lines showed similar results, with some exceptions (supplementary Fig. 1S). The gene discussed is EGFR; the disease is colorectal carcinoma.